Top 10 Things to Know About Today’s Sex Drive Drugs

Though both medications have taken their turns being dubbed the "female Viagra" in media reports, they are very different from the little blue pill. Viagra helps men who already want to have sex but are not able to physiologically. It is taken on an as-needed basis to help increase blood flow to the penis.

In contrast, Addyi changes brain chemistry in women to help them want to have sex and must be taken every day. Vyleesi, while taken on an as-need basis, is an injection that targets brain hormones to try and change a woman’s sexual desire.

Pass On The Pink Pill Or Pass Out Banner

Help consumers! Report problems with sex drive drugs.

If you experience a problem, side effect, or other adverse reaction after taking Addyi or Vyleesi, consider reporting it at MedWatch, the FDA’s reporting system for drugs and medical device adverse events.

Highlighted Content Related To Sex Drugs for Women:

How Can I Get an Addyi Prescription if My Insurance Does Not Cover It?

Comments Off on How Can I Get an Addyi Prescription if My Insurance Does Not Cover It?

Women’s Health Leader Available for Interviews on Poor Sales of Women’s Sex Drug Addyi and Launch of New Campaign

Comments Off on Women’s Health Leader Available for Interviews on Poor Sales of Women’s Sex Drug Addyi and Launch of New Campaign

The NWHN Advises Women to Be Cautious About Using Flibanserin Until New Studies Are Fully Vetted

Comments Off on The NWHN Advises Women to Be Cautious About Using Flibanserin Until New Studies Are Fully Vetted

Flibanserin Update: Health and Safety Concerns Continue to Be Profound

Comments Off on Flibanserin Update: Health and Safety Concerns Continue to Be Profound

Female Viagra? A Pro-Sex Feminist Says No

Comments Off on Female Viagra? A Pro-Sex Feminist Says No

The National Women’s Health Network Expresses Profound Disappointment With FDA’s Decision to Approve Controversial Sex Drug.

Comments Off on The National Women’s Health Network Expresses Profound Disappointment With FDA’s Decision to Approve Controversial Sex Drug.